Dödligt virus från Kina orsakar panik (SARS-CoV-2, COVID-19)

The strength of our study was its double-blind structure with more substantial outcomes such as Ct values and culture viability where the laboratory personnel did not have any information concerning the patients’ assignment. In conclusion, our study strongly supports the notion that ivermectin has anti-SARS-CoV-2 activity. If used at the early stage of disease onset, it may shorten the isolation time and reduce transmission. Further studies are needed to test its ability to prevent clinical deterioration for high-risk groups and to examine its potential as a prophylactic drug. Vaccines are now starting to become available, but it will take years before they are distributed worldwide. As this drug may also reduce mortality, urgent intervention with further well-designed studies are needed.